| DAWN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DAWN shares outstanding history going back to 5/27/2021:
Also see: DAWN Market Cap History DAWN YTD Return |
DAWN Shares Outstanding History — Day One Biopharmaceuticals Share Count Over Time
As of 4/15/2026 Day One Biopharmaceuticals has 103.33 million DAWN shares outstanding. Investors often track the DAWN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DAWN share count trends over time, with 20 historical shares outstanding datapoints presented, dating back to 5/27/2021.
| DAWN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||
DAWN Historical Shares Outstanding: +12.25% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| DAWN Stock Price Chart |
| About Day One Biopharmaceuticals Inc |
| Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. Co. partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its product candidates include tovorafenib, pimasertib and the VRK1 program. Co.'s lead product candidate, tovorafenib, is an investigational, oral, brain-penetrant, highly selective type II RAF kinase inhibitor. Co.'s pipeline also includes pimasertib, an investigational, oral, highly selective small molecule inhibitor of mitogen-activated protein kinases 1 and 2 (MEK-1/-2). We show 20 historical shares outstanding datapoints in our coverage of DAWN's shares outstanding history. Understanding the changing numbers of DAWN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DAWN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DAWN by allowing them to research DAWN shares outstanding history as well as any other stock in our coverage universe. |
| DAWN Current Stock Quote |
Quotes delayed 20 minutes  Free DAWN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DAWN Share Performance |
| Shares Outstanding Peers |
| Day One Biopharmaceuticals (DAWN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DBTX Shares Outstanding History DCGO Shares Outstanding History DCOY Shares Outstanding History DCPH Shares Outstanding History DCTH Shares Outstanding History DEPO Shares Outstanding History DERM Shares Outstanding History DFFN Shares Outstanding History DFTX Shares Outstanding History DGX Shares Outstanding History More Healthcare companies » |
DAWN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
